TGFB1 and diabetes mellitus: LRG1, or leucine-rich α–2 glycoprotein 1, has been shown to promote angiogenesis by modulating TGF-β signaling (Wang et al., 2013), and this process has been implicated in various complications of diabetes (Hong et al., 2019; Liu et al., 2020; Zhang et al., 2019).